✦ LIBER ✦

Monthly corticosteroids decrease neutralizing antibodies to IFNβ1b: a randomized trial in multiple sclerosis

✍ Scribed by Pozzilli, Carlo; Antonini, Giovanni; Bagnato, Francesca; Mainero, Caterina; Tomassini, Valentina; Onesti, Emanuela; Fantozzi, Roberta; Galgani, Simona; Pasqualetti, Patrizio; Millefiorini, Enrico

Book ID: 113012310
Publisher: Springer
Year: 2002
Tongue: English
Weight: 348 KB
Volume: 249
Category: Article
ISSN: 0340-5354
DOI: 10.1007/pl00007847

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Validating parameters of a luciferase re

Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNβ in multiple sclerosis patients

✍ Regina Lam; Rachel Farrell; Tariq Aziz; Ebrima Gibbs; Gavin Giovannoni; Sidney G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 380 KB

Further study on the specificity and inc

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

✍ Guido Antonelli; Eleonora Simeoni; Francesca Bagnato; Carlo Pozzilli; Ombretta T 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 66 KB

A case study on the effect of neutralizi

A case study on the effect of neutralizing antibodies to interferon beta 1b in multiple sclerosis patients followed for 3 years with monthly imaging

✍ A. W. Chiu; M. Ehrmantraut; N. D. Richert; V. N. Ikonomidou; S. Pellegrini; H. F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Effect of interferon-β1b on magnetic res

Effect of interferon-β1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: Results of a European multicenter, randomized, double-blind, placebo-controlled trial

✍ D. H. Miller; P. D. Molyneux; G. J. Barker; D. G. MacManus; I. F. Moseley; K. Wa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

A randomised, double blind, placebo cont

A randomised, double blind, placebo controlled trial with vitamin D 3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

✍ Soilu-Hänninen, Merja (author);Åivo, Julia (author);Lindström, Britt Marie (auth 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 153 KB

A prospective, open-label treatment tria

A prospective, open-label treatment trial to compare the effect of IFN -1a (Avonex(R)), IFN -1b (Betaseron(R)), and glatiramer acetate (Copaxone(R)) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapy

✍ Khan, O. A; Tselis, A. C; Kamholz, J. A; Garbern, J. Y; Lewis, R. A; Lisak, R. P 📂 Article 📅 2001 🏛 SAGE Publications 🌐 English ⚖ 95 KB